Carcinoma

Oncology·MeSH: Cholangiocarcinoma

Prevalence

14.0 / 100K

Incidence

6.0 / 100K/yr

847 drugs in development·184 companies·8 clinical trials

Drug Pipeline by Phase

Approved(36)

Drug	Company
afinitor	Novartis AG (NVS)
axitinib	Aptinyx Inc. (APTX)
Aybintio (SB8)	Organon & Co. (OGN)
bicalutamide	Aptinyx Inc. (APTX)
bicalutamide	SUNSET ISLAND GROUP (SUN)
CABOMETYX	EXELIXIS, INC. (EXEL)
calcium gluconate in	Amneal Pharmaceuticals, Inc. (AMRX)
cinacalcet	DR REDDYS LABORATORIES LTD (RDY)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
Cyramza	ELI LILLY & Co (LLY)
Cyramza®	ELI LILLY & Co (LLY)
docetaxel	PFIZER INC (PFE)
Erivedge	CURIS INC (CRIS)
esoguard	Lucid Diagnostics Inc. (LUCD)
hydroxyurea	AVEDRO INC (AVDR)
keytruda qlex	Merck & Co., Inc. (MRK)
Lenvima	Merck & Co., Inc. (MRK)
loqtorzi	Coherus Oncology, Inc. (CHRS)
lyumjev	ELI LILLY & Co (LLY)
ogivri	Mylan II B.V. (MYL)
onivyde	MERRIMACK PHARMACEUTICALS INC (MACK)
Ontruzant (SB3)	Organon & Co. (OGN)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
proleukin	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Retevmo	ELI LILLY & Co (LLY)
Retevmo®	ELI LILLY & Co (LLY)
sodium	Amneal Pharmaceuticals, Inc. (AMRX)
sodium nitroprusside	Amneal Pharmaceuticals, Inc. (AMRX)
tevimbra	BeOne Medicines Ltd. (ONC)
Tyvyt	ELI LILLY & Co (LLY)
Tyvyt®	ELI LILLY & Co (LLY)
unloxcyt	Checkpoint Therapeutics, Inc. (CKPT)
unloxcyt	Fortress Biotech Inc. (FBIO)
unloxcyt	Fortress Biotech Inc. (FBIO)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)
ZYNYZ	MACROGENICS INC (MGNX)

Phase 3(269)

Drug	Company
(osimertinib cohort	ASTRAZENECA PLC (AZN)
[18F]FAPI-74 PET/CT	ENANTA PHARMACEUTICALS INC (ENTA)
5-flurouracil	GH Research PLC (GHRS)
5-FU	Tango Therapeutics, Inc. (TNGX)
Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
Adagrasib	ENANTA PHARMACEUTICALS INC (ENTA)
Ameluz®	Biofrontera Inc. (BFRI)
amezalpat	Tempest Therapeutics, Inc. (TPST)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab iv	GH Research PLC (GHRS)
amivantamab sc	GH Research PLC (GHRS)
anti-thymocyte globulin	Filana Therapeutics Inc. (FLNA)
Apalutamide	Myovant Sciences Ltd. (MYOV)
Apalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Apalutamide	Crinetics Pharmaceuticals, Inc. (CRNX)
Apalutamide 60 mg or 240 mg tablets	KYNTRA BIO INC. (KYNB)
ARM C FOLFIRI	IGM Biosciences, Inc. (IGMS)
avelumab	CG Oncology, Inc. (CGON)
avelumab	GH Research PLC (GHRS)
Avelumab	Royalty Pharma plc (RPRX)
Avelumab	Merus N.V. (MRUS)
AZD0901	ASTRAZENECA PLC (AZN)
AZD2936	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
azd9291 80 mg/40 mg	ASTRAZENECA PLC (AZN)
azenosertib	Zentalis Pharmaceuticals, Inc. (ZNTL)
azenosertib (ZN-c3)	Zentalis Pharmaceuticals, Inc. (ZNTL)
Balstilimab	ENANTA PHARMACEUTICALS INC (ENTA)
Base-edited hematopoietic stem and progenitor cells	Merus N.V. (MRUS)
batiraxcept	Aravive, Inc. (ARAV)
Bavituximab	Merck & Co., Inc. (MRK)
bcg	GH Research PLC (GHRS)
bcg tokyo-172 strain	GH Research PLC (GHRS)
bcg tokyo-172 strain vaccine	GH Research PLC (GHRS)
Belzutifan	Merck & Co., Inc. (MRK)
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
bgb-a445	BeOne Medicines Ltd. (ONC)
BGB-A445	BeOne Medicines Ltd. (ONC)
Bicalutamide	ARS Pharmaceuticals, Inc. (SPRY)
brachytherapy	GH Research PLC (GHRS)
Cabazitaxel	KYNTRA BIO INC. (KYNB)
cabozantinib	GH Research PLC (GHRS)
Cabozantinib	BRISTOL MYERS SQUIBB CO (BMY)
Cabozantinib	Royalty Pharma plc (RPRX)
Cabozantinib S-malate	Royalty Pharma plc (RPRX)
Cadonilimab	Merus N.V. (MRUS)
Calcio levofolinate	IGM Biosciences, Inc. (IGMS)
Camrelizumab and Cetuximab	FATE THERAPEUTICS INC (FATE)
Camrelizumab and Chemotherapy	FATE THERAPEUTICS INC (FATE)
Camrelizumab and Chemotherapy	Amneal Pharmaceuticals, Inc. (AMRX)
CAN-2409	Candel Therapeutics, Inc. (CADL)
capmatinib	GH Research PLC (GHRS)
CAR-T cell	Filana Therapeutics Inc. (FLNA)
Casdatifan	ASTRAZENECA PLC (AZN)
casdatifan (AB521)	Arcus Biosciences, Inc. (RCUS)
cemiplimab	GH Research PLC (GHRS)
Cemiplimab	ENANTA PHARMACEUTICALS INC (ENTA)
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
Ceralasertib	Relay Therapeutics, Inc. (RLAY)
Ceralasertib	Crinetics Pharmaceuticals, Inc. (CRNX)
Ceralasertib	ADMA BIOLOGICS, INC. (ADMA)
Ceralasertib	ENANTA PHARMACEUTICALS INC (ENTA)
cetuximab	ASTRAZENECA PLC (AZN)
cetuximab	Innovation Pharmaceuticals Inc. (IPIX)
cetuximab	AVEO PHARMACEUTICALS, INC. (AVEO)
cetuximab	JOHNSON & JOHNSON (JNJ)
cetuximab	GH Research PLC (GHRS)
Cetuximab	FATE THERAPEUTICS INC (FATE)
Cetuximab Sarotalocan Sodium	FATE THERAPEUTICS INC (FATE)
Cetuximab Sarotalocan Sodium	Amneal Pharmaceuticals, Inc. (AMRX)
CGT4859	Cogent Biosciences, Inc. (COGT)
chemotherapy	GH Research PLC (GHRS)
chemotherapy	GH Research PLC (GHRS)
Chemotherapy	Amneal Pharmaceuticals, Inc. (AMRX)
Chemotherapy	IGM Biosciences, Inc. (IGMS)
clobetasol	GH Research PLC (GHRS)
clostridium butyricum cbm 588 probiotic strain	GH Research PLC (GHRS)
Concurrent chemotherapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Crizotinib	BRISTOL MYERS SQUIBB CO (BMY)
dabrafenib	GH Research PLC (GHRS)
Datopotamab Deruxtecan	Merck & Co., Inc. (MRK)
degarelix	GH Research PLC (GHRS)
degarelix	KYNTRA BIO INC. (KYNB)
derazantinib	ARQULE INC (ARQL)
Docetetaxel	Merck & Co., Inc. (MRK)
EGFR-TKI inhibitor based on investigator's choice	Merus N.V. (MRUS)
Enfortumab Vedotin	Merck & Co., Inc. (MRK)
Ensartinib	ENANTA PHARMACEUTICALS INC (ENTA)
Ensartinib	Merus N.V. (MRUS)
epacadostat	Incyte Corp. (INCY)
Erbitux®	FATE THERAPEUTICS INC (FATE)
Erbitux®	Amneal Pharmaceuticals, Inc. (AMRX)
Eribulin Mesylate	Arbutus Biopharma Corp (ABUS)
Erlotinib	Amneal Pharmaceuticals, Inc. (AMRX)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
Etoposide	ADMA BIOLOGICS, INC. (ADMA)
Evolocumab	UNITED THERAPEUTICS Corp (UTHR)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
ficerafusp alfa (formerly BCA101)	Bicara Therapeutics Inc. (BCAX)
ficlatuzumab	AVEO PHARMACEUTICALS, INC. (AVEO)
flot chemotherapy	ASTRAZENECA PLC (AZN)
fludarabine	Filana Therapeutics Inc. (FLNA)
Flutamide	ARS Pharmaceuticals, Inc. (SPRY)
FOLFIRI + Zimberelimab + Domvanalimab	IGM Biosciences, Inc. (IGMS)
FOLFIRI or FOLFOX or Regorafenib	IGM Biosciences, Inc. (IGMS)
FOLFIRI regimen	Merus N.V. (MRUS)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
Folfirinox	Tango Therapeutics, Inc. (TNGX)
FOLFIRINOX neoadjuvant chemotherapy	Merus N.V. (MRUS)
FOLFOX	KYNTRA BIO INC. (KYNB)
FOLFOX	Merus N.V. (MRUS)
FOLFOX neoadjuvant chemotherapy	Merus N.V. (MRUS)
FOLFOX-4	IGM Biosciences, Inc. (IGMS)
FOLFOX-7	IGM Biosciences, Inc. (IGMS)
folinic acid	Merus N.V. (MRUS)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
goserelin	KYNTRA BIO INC. (KYNB)
goserelin	GH Research PLC (GHRS)
goserelin	GH Research PLC (GHRS)
Goserelin acetate	KYNTRA BIO INC. (KYNB)
HER3-DXd	Merck & Co., Inc. (MRK)
histrelin acetate	KYNTRA BIO INC. (KYNB)
hmpl-453	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Ltd (HMDCF)
horse anti-thymocyte globulin	Filana Therapeutics Inc. (FLNA)
Hyperthermic Intraperitoneal Chemotherapy	Merus N.V. (MRUS)
I-DXd	Merck & Co., Inc. (MRK)
Ifosfamide	UNITED THERAPEUTICS Corp (UTHR)
ifx-2.0	TuHURA Biosciences, Inc./NV (HURA)
ifx2.0	TuHURA Biosciences, Inc./NV (HURA)
Immune Checkpoint Inhibitor	Merus N.V. (MRUS)
Immune induction therapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Immunomaintenance therapy	Crinetics Pharmaceuticals, Inc. (CRNX)
incagn02390	Incyte Corp. (INCY)
Intismeran autogene	Merus N.V. (MRUS)
Intismeran autogene	Merck & Co., Inc. (MRK)
intravenous tislelizumab	BeOne Medicines Ltd. (ONC)
Intravenous Tislelizumab	BeOne Medicines Ltd. (ONC)
Investigator's Choice	Merus N.V. (MRUS)
Ivosidenib	AGIOS PHARMACEUTICALS, INC. (AGIO)
Ivosidenib Oral Tablet	AGIOS PHARMACEUTICALS, INC. (AGIO)
l-leucovorin	Merus N.V. (MRUS)
lanreotide	GH Research PLC (GHRS)
lazertinib	GH Research PLC (GHRS)
lenvatinib	GH Research PLC (GHRS)
lenvatinib	BRISTOL MYERS SQUIBB CO (BMY)
Lenvatinib	ASTRAZENECA PLC (AZN)
leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin Calcium	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin Calcium	Arcus Biosciences, Inc. (RCUS)
Leucovorin Calcium	Merus N.V. (MRUS)
Leucovorin/levofolinate calcium	Merus N.V. (MRUS)
Leucovorin/levofolinate calcium	Merck & Co., Inc. (MRK)
leuprolide	GH Research PLC (GHRS)
leuprolide	GH Research PLC (GHRS)
Leuprolide	KYNTRA BIO INC. (KYNB)
Leuprolide acetate	KYNTRA BIO INC. (KYNB)
Levoleucovorin	Merck & Co., Inc. (MRK)
LY3537982	ELI LILLY & Co (LLY)
MCLA-158 (petosemtamab)	Merus N.V. (MRUS)
MEDI4736	ASTRAZENECA PLC (AZN)
MEDI4736+Tremelimumab	ASTRAZENECA PLC (AZN)
mFOLFIRINOX infusion	Tango Therapeutics, Inc. (TNGX)
milademetan	Rain Oncology Inc. (RAIN)
minocycline	GH Research PLC (GHRS)
Mitomycin	Merus N.V. (MRUS)
Mitomycin-C	Merus N.V. (MRUS)
MK-0482	Merck & Co., Inc. (MRK)
MK-3120	Merck & Co., Inc. (MRK)
MK-3475	Merck & Co., Inc. (MRK)
MK-4830	Merck & Co., Inc. (MRK)
Multikine	CEL SCI CORP (CVM)
nadofaragene firadenovec	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Nadofaragene Firadenovec	Merus N.V. (MRUS)
nbtxr3	LianBio (LIANY)
Neoadjuvant olaparib	ENANTA PHARMACEUTICALS INC (ENTA)
Neratinib	ENANTA PHARMACEUTICALS INC (ENTA)
New Formulation of Niraparib and Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
New Formulation of Niraparib and Abiraterone Acetate	Royalty Pharma plc (RPRX)
Nilutamide	ARS Pharmaceuticals, Inc. (SPRY)
Niraparib	ARS Pharmaceuticals, Inc. (SPRY)
nis793	Novartis AG (NVS)
nofazinlimab	EQRx, Inc. (EQRX)
Olaparib	Merck & Co., Inc. (MRK)
OP-1250	Olema Pharmaceuticals, Inc. (OLMA)
open-label azd9291 80 mg/40 mg	ASTRAZENECA PLC (AZN)
osimertinib	GH Research PLC (GHRS)
Osimertinib	Amneal Pharmaceuticals, Inc. (AMRX)
osimertinib 80 mg/40 mg	ASTRAZENECA PLC (AZN)
ozuriftamab vedotin	BioAtla, Inc. (BCAB)
panitumumab	GH Research PLC (GHRS)
pazopanib	Incyte Corp. (INCY)
PD-1 inhibitor	Merus N.V. (MRUS)
pds0101	PDS Biotechnology Corp (PDSB)
Pemetrexed	ELI LILLY & Co (LLY)
Pemetrexed Disodium	ADMA BIOLOGICS, INC. (ADMA)
Pemetrexed Disodium	ENANTA PHARMACEUTICALS INC (ENTA)
pemigatinib	Incyte Corp. (INCY)
Pertuzumab	Filana Therapeutics Inc. (FLNA)
petosemtamab	Merus N.V. (MRUS)
Petosemtamab (MCLA-158)	Merus N.V. (MRUS)
platinum based chemotherapy	GH Research PLC (GHRS)
Procarbazine Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Pumitamig	BRISTOL MYERS SQUIBB CO (BMY)
rabbit anti-thymocyte globulin	Filana Therapeutics Inc. (FLNA)
ramucirumab	GH Research PLC (GHRS)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
Regorafenib	UNITED THERAPEUTICS Corp (UTHR)
relacorilant	CORCEPT THERAPEUTICS INC (CORT)
Relugolix	Myovant Sciences Ltd. (MYOV)
Relugolix Combination Tablet	Myovant Sciences Ltd. (MYOV)
renovogem	RenovoRx, Inc. (RNXT)
Repotrectinib	BRISTOL MYERS SQUIBB CO (BMY)
retifanlimab	Incyte Corp. (INCY)
rigosertib	TRAWS PHARMA, INC. (ONTX)
rocapuldencel-t	ARGOS THERAPEUTICS INC (ARGS)
rp1 in combination with nivolumab	Replimune Group, Inc. (REPL)
RPH-002	FATE THERAPEUTICS INC (FATE)
RPH-002	Amneal Pharmaceuticals, Inc. (AMRX)
Rucaparib camsylate	KYNTRA BIO INC. (KYNB)
Sacituzumab Govitecan	Arbutus Biopharma Corp (ABUS)
savolitinib	ASTRAZENECA PLC (AZN)
Selpercatinib	ELI LILLY & Co (LLY)
Standard adjuvant chemotherapy	Merus N.V. (MRUS)
Sturlimogene Erparepvec	Replimune Group, Inc. (REPL)
subcutaneous tislelizumab	BeOne Medicines Ltd. (ONC)
Subcutaneous Tislelizumab	BeOne Medicines Ltd. (ONC)
sugemalimab	EQRx, Inc. (EQRX)
Supportive care measures	Merck & Co., Inc. (MRK)
tak-676	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-676	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-788	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-788	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Tarlatamab	IGM Biosciences, Inc. (IGMS)
Tarlatamab	Merus N.V. (MRUS)
Tarlatamab	REGENXBIO Inc. (RGNX)
Temozolomide	IGM Biosciences, Inc. (IGMS)
tepotinib	GH Research PLC (GHRS)
tislelizumab	BeOne Medicines Ltd. (ONC)
tivozanib	AVEO PHARMACEUTICALS, INC. (AVEO)
Tivozanib	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Topotecan	Merus N.V. (MRUS)
Toripalimab	Crinetics Pharmaceuticals, Inc. (CRNX)
TP regimen	Merus N.V. (MRUS)
tpst-1120	Tempest Therapeutics, Inc. (TPST)
trametinib	GH Research PLC (GHRS)
tremelimumab	CG Oncology, Inc. (CGON)
Tremelimumab	ASTRAZENECA PLC (AZN)
triptorelin	GH Research PLC (GHRS)
triptorelin	GH Research PLC (GHRS)
truseltiq	BridgeBio Pharma, Inc. (BBIO)
Tucatinib	PFIZER INC (PFE)
ugn-104	UroGen Pharma Ltd. (URGN)
Vepugratinib	ELI LILLY & Co (LLY)
Vibostolimab	Merck & Co., Inc. (MRK)
Vinblastine	ASTRAZENECA PLC (AZN)
vinorelbine	MAIA Biotechnology, Inc. (MAIA)
Volrustomig	ASTRAZENECA PLC (AZN)
Vudalimab	KYNTRA BIO INC. (KYNB)
zanidatamab	GH Research PLC (GHRS)
Zanidatamab	Merus N.V. (MRUS)
Zanzalintinib	Merck & Co., Inc. (MRK)
zolbetuximab	Merus N.V. (MRUS)

Phase 2(254)

Drug	Company
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
6-thio-2'-deoxyguanosine	MAIA Biotechnology, Inc. (MAIA)
9MW2821	Crinetics Pharmaceuticals, Inc. (CRNX)
abc294640	RedHill Biopharma Ltd. (RDHL)
ABT-869	AbbVie Inc. (ABBV)
ACR-368	Acrivon Therapeutics, Inc. (ACRV)
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5	CG Oncology, Inc. (CGON)
AG-120	AGIOS PHARMACEUTICALS, INC. (AGIO)
ALLO-316	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
ALN-BCAT	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Amivantamab	Structure Therapeutics Inc. (GPCR)
Amivantamab and Recombinant Human Hyaluronidase	Structure Therapeutics Inc. (GPCR)
Amivantamab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Amivantamab IV	Bausch Health Companies Inc. (BHC)
Amivantamab IV	Structure Therapeutics Inc. (GPCR)
Amivantamab SC	Structure Therapeutics Inc. (GPCR)
Amivantamab SC	Bausch Health Companies Inc. (BHC)
anlotinib	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
Anti-GPC3-CAR Autologous T Lymphocytes	Filana Therapeutics Inc. (FLNA)
Antiandrogen Therapy	Myovant Sciences Ltd. (MYOV)
Antiandrogen Therapy	Janux Therapeutics, Inc. (JANX)
Antiandrogen Therapy	ARS Pharmaceuticals, Inc. (SPRY)
Antiandrogen Therapy	Royalty Pharma plc (RPRX)
Arginine hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Arm A - Olaparib	IGM Biosciences, Inc. (IGMS)
Autogene cevumeran	Merus N.V. (MRUS)
Autogene cevumeran	Tango Therapeutics, Inc. (TNGX)
Avelumab	Structure Therapeutics Inc. (GPCR)
Avelumab	NEKTAR THERAPEUTICS (NKTR)
azd5851	ASTRAZENECA PLC (AZN)
AZD6738	Merus N.V. (MRUS)
balstililmab	AGENUS INC (AGEN)
BET Bromodomain Inhibitor ZEN-3694	KYNTRA BIO INC. (KYNB)
Binimetinib	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Boserolimab	Merus N.V. (MRUS)
Boserolimab	Merck & Co., Inc. (MRK)
Botensilimab	ENANTA PHARMACEUTICALS INC (ENTA)
Branched-Chain Amino Acids	ENANTA PHARMACEUTICALS INC (ENTA)
Budigalimab	AbbVie Inc. (ABBV)
BXCL701	BioXcel Therapeutics, Inc. (BTAI)
BXCL701	Merck & Co., Inc. (MRK)
cabozantinib	CG Oncology, Inc. (CGON)
Cabozantinib	ENANTA PHARMACEUTICALS INC (ENTA)
Cabozantinib	UNITED THERAPEUTICS Corp (UTHR)
Cabozantinib S-malate	ENANTA PHARMACEUTICALS INC (ENTA)
casdozokitug	Coherus Oncology, Inc. (CHRS)
cemiplimab	Replimune Group, Inc. (REPL)
cemiplimab	MAIA Biotechnology, Inc. (MAIA)
cemiplimab	West Pharmaceutical Services Inc. (WST)
Cemiplimab	Assertio Holdings, Inc. (ASRT)
Cemiplimab	FATE THERAPEUTICS INC (FATE)
Cemiplimab	Merus N.V. (MRUS)
Cemiplimab	ELI LILLY & Co (LLY)
Cemiplimab	Royalty Pharma plc (RPRX)
Cemiplimab	ADMA BIOLOGICS, INC. (ADMA)
Cemiplimab 350 mg IV	Merus N.V. (MRUS)
ceralasertib	GH Research PLC (GHRS)
certepetide	LISATA THERAPEUTICS, INC. (LSTA)
cetuximab	Verastem, Inc. (VSTM)
Cetuximab	Structure Therapeutics Inc. (GPCR)
Cetuximab	ADMA BIOLOGICS, INC. (ADMA)
Chemotherapeutic Agent	Merus N.V. (MRUS)
chlorhexidine	GH Research PLC (GHRS)
clindamycin	GH Research PLC (GHRS)
Clobetasol	Bausch Health Companies Inc. (BHC)
Clobetasol Propionate	UNITED THERAPEUTICS Corp (UTHR)
cmp-001	CHECKMATE PHARMACEUTICALS, INC. (CMPI)
concurrent chemo/radiation therapy	Innovation Pharmaceuticals Inc. (IPIX)
concurrent chemo/radiation therapy	JOHNSON & JOHNSON (JNJ)
Copanlisib Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Crizotinib	Amneal Pharmaceuticals, Inc. (AMRX)
CTLA-4 Antibody	Crinetics Pharmaceuticals, Inc. (CRNX)
Cyclophophamide	Allogene Therapeutics, Inc. (ALLO)
cylembio	IO Biotech, Inc. (IOBT)
dabogratinib	Tyra Biosciences, Inc. (TYRA)
Dabogratinib TBD	Tyra Biosciences, Inc. (TYRA)
Defactinib Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Degarelix	ARS Pharmaceuticals, Inc. (SPRY)
Diclofenac Potassium	ENANTA PHARMACEUTICALS INC (ENTA)
disitamab vedotin	PFIZER INC (PFE)
domvanalimab	GILEAD SCIENCES, INC. (GILD)
DOMVANALIMAB	IGM Biosciences, Inc. (IGMS)
Dostarlimab	Merus N.V. (MRUS)
Dostarlimab	IGM Biosciences, Inc. (IGMS)
Doxycycline	Bausch Health Companies Inc. (BHC)
Eflornithine Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
enmd-2076	CASI Pharmaceuticals, Inc. (CASIF)
Ensartinib	ADMA BIOLOGICS, INC. (ADMA)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
erlotinib	CG Oncology, Inc. (CGON)
Erlotinib	ADMA BIOLOGICS, INC. (ADMA)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
fdc fianlimab+cemiplimab	West Pharmaceutical Services Inc. (WST)
Fianlimab	ADMA BIOLOGICS, INC. (ADMA)
FID-007	Fulgent Genetics Inc. (FLGT)
FID007	Fulgent Genetics Inc. (FLGT)
Filgrastim	Replimune Group, Inc. (REPL)
FLOT	Arcus Biosciences, Inc. (RCUS)
Fludarabine	Allogene Therapeutics, Inc. (ALLO)
folfox regimen	LISATA THERAPEUTICS, INC. (LSTA)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
FOLFOX regimen	IGM Biosciences, Inc. (IGMS)
Gallium Ga 68 Gozetotide	UNITED THERAPEUTICS Corp (UTHR)
gedeptin	GeoVax Labs, Inc. (GOVX)
Gemzar	Zentalis Pharmaceuticals, Inc. (ZNTL)
Goserelin	ENANTA PHARMACEUTICALS INC (ENTA)
Goserelin Acetate	Royalty Pharma plc (RPRX)
Goserelin Acetate	ARS Pharmaceuticals, Inc. (SPRY)
GSK5764227	Merus N.V. (MRUS)
had5-hpv vaccine	ImmunityBio, Inc. (IBRX)
HER3-DXd	Merus N.V. (MRUS)
Histrelin	KYNTRA BIO INC. (KYNB)
HRS-4642+AG+Nimotuzumab	Merus N.V. (MRUS)
IM96 CAR-T Cells	Merus N.V. (MRUS)
Immune checkpoint inhibitor	KYNTRA BIO INC. (KYNB)
incagn02385	Incyte Corp. (INCY)
incb062079	Incyte Corp. (INCY)
incb099280	Incyte Corp. (INCY)
increase dose of tocilizumab	Merus N.V. (MRUS)
ino-3112	INOVIO PHARMACEUTICALS, INC. (INO)
Ivonescimab	IGM Biosciences, Inc. (IGMS)
JNJ-90301900	Merus N.V. (MRUS)
Lazertinib	Bausch Health Companies Inc. (BHC)
Lazertinib	Structure Therapeutics Inc. (GPCR)
lenvatinib	CG Oncology, Inc. (CGON)
Lenvatinib	ENANTA PHARMACEUTICALS INC (ENTA)
Lenvatinib	UNITED THERAPEUTICS Corp (UTHR)
Lenvatinib Mesylate	UNITED THERAPEUTICS Corp (UTHR)
Leronlimab	CytoDyn Inc. (CYDY)
Leucovorin	UNITED THERAPEUTICS Corp (UTHR)
Leucovorin	AbbVie Inc. (ABBV)
Leucovorin	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Leucovorin	Jazz Pharmaceuticals plc (JAZZ)
Leucovorin Calcium	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Leuprolide	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	ARS Pharmaceuticals, Inc. (SPRY)
Leuprolide Acetate	Royalty Pharma plc (RPRX)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
Levoleucovorin Calcium	UNITED THERAPEUTICS Corp (UTHR)
LN-145	ENANTA PHARMACEUTICALS INC (ENTA)
LN-145	Merus N.V. (MRUS)
LN-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LN-145	Filana Therapeutics Inc. (FLNA)
Long-acting leronlimab	CytoDyn Inc. (CYDY)
lp-300	Lantern Pharma Inc. (LTRN)
lsta1	LISATA THERAPEUTICS, INC. (LSTA)
Lutetium Lu 177 Vipivotide Tetraxetan	KYNTRA BIO INC. (KYNB)
m6223	GH Research PLC (GHRS)
M6223	NEKTAR THERAPEUTICS (NKTR)
Maximum Tolerated Dose of leronlimab	CytoDyn Inc. (CYDY)
Methoxyamine	ADMA BIOLOGICS, INC. (ADMA)
Methoxyamine	ENANTA PHARMACEUTICALS INC (ENTA)
Methoxyamine	Merus N.V. (MRUS)
mFOLFOX	Jazz Pharmaceuticals plc (JAZZ)
mFOLFOX/FOLFIRI	KYNTRA BIO INC. (KYNB)
Mitomycin	ENANTA PHARMACEUTICALS INC (ENTA)
Mitomycin C	ENANTA PHARMACEUTICALS INC (ENTA)
Montanide ISA 51 VG	ENANTA PHARMACEUTICALS INC (ENTA)
Montanide ISA 51 VG	Filana Therapeutics Inc. (FLNA)
montelukast	GH Research PLC (GHRS)
Neratinib	Filana Therapeutics Inc. (FLNA)
Nilotinib Hydrochloride Monohydrate	ENANTA PHARMACEUTICALS INC (ENTA)
Niraparib	Royalty Pharma plc (RPRX)
Niraparib	IGM Biosciences, Inc. (IGMS)
nktr-255	GH Research PLC (GHRS)
Nogapendekin Alfa	CG Oncology, Inc. (CGON)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
Olaparib	ENANTA PHARMACEUTICALS INC (ENTA)
Olaparib	Crinetics Pharmaceuticals, Inc. (CRNX)
Olaparib	ADMA BIOLOGICS, INC. (ADMA)
OSE2101	IGM Biosciences, Inc. (IGMS)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)
part 1	Verrica Pharmaceuticals Inc. (VRCA)
part 2	Verrica Pharmaceuticals Inc. (VRCA)
PD-1antibody plus GEMOX	Merus N.V. (MRUS)
Pegfilgrastim	Replimune Group, Inc. (REPL)
Pegfilgrastim	Assertio Holdings, Inc. (ASRT)
Pemetrexed	Amneal Pharmaceuticals, Inc. (AMRX)
PF-08634404	Merus N.V. (MRUS)
platinum compound	GH Research PLC (GHRS)
propranolol	GH Research PLC (GHRS)
Propranolol	Bausch Health Companies Inc. (BHC)
Propranolol Hydrochloride	UNITED THERAPEUTICS Corp (UTHR)
Propranolol Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
QL1706	ENANTA PHARMACEUTICALS INC (ENTA)
Raludotatug Deruxtecan	Merck & Co., Inc. (MRK)
ramucirumab	Sanofi (SNY)
Ramucirumab	Jazz Pharmaceuticals plc (JAZZ)
Recombinant human tissue kallikrein	Merus N.V. (MRUS)
Relatlimab	ENANTA PHARMACEUTICALS INC (ENTA)
Relugolix	KYNTRA BIO INC. (KYNB)
Relugolix	ENANTA PHARMACEUTICALS INC (ENTA)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP)
rp1	Replimune Group, Inc. (REPL)
RP2 Monotherapy	Replimune Group, Inc. (REPL)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
sacituzumab govitecan	GH Research PLC (GHRS)
Sacituzumab Govitecan	NEKTAR THERAPEUTICS (NKTR)
Sacituzumab Govitecan	FATE THERAPEUTICS INC (FATE)
sar444245	Sanofi (SNY)
Sargramostim	Filana Therapeutics Inc. (FLNA)
saruparib	GH Research PLC (GHRS)
Serplulimab	ENANTA PHARMACEUTICALS INC (ENTA)
Setanaxib	Calliditas Therapeutics AB (CALT)
si-b001	NYMOX PHARMACEUTICAL CORP (NYMXF)
Sodium Fluoride F-18	Amneal Pharmaceuticals, Inc. (AMRX)
Sodium Fluoride F-18	ENANTA PHARMACEUTICALS INC (ENTA)
Sodium Fluoride F-18	ADMA BIOLOGICS, INC. (ADMA)
srf388	Coherus Oncology, Inc. (CHRS)
STRO-002 (luveltamab tazevibulin, luvelta)	SUTRO BIOPHARMA, INC. (STRO)
suba-itraconazole bccns	Inhibitor Therapeutics, Inc. (INTI)
SVN53-67/M57-KLH Peptide Vaccine	Filana Therapeutics Inc. (FLNA)
Talazoparib	KYNTRA BIO INC. (KYNB)
tas-120	CG Oncology, Inc. (CGON)
timolol	GH Research PLC (GHRS)
Timolol	Bausch Health Companies Inc. (BHC)
Tivozanib	Replimune Group, Inc. (REPL)
Tocilizumab	Arcus Biosciences, Inc. (RCUS)
tqb2618	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tqb2618 injection; penpulimab	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tqb3616	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tremelimumab	AC Immune SA (ACIU)
triptorelin	KYNTRA BIO INC. (KYNB)
tti-101	Tvardi Therapeutics, Inc. (TVRD)
Tucatinib	Merus N.V. (MRUS)
tusamitamab ravtansine	Sanofi (SNY)
TYRA-200	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.125 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.25 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.375 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.50 mg/kg	Tyra Biosciences, Inc. (TYRA)
ubamatamab	REGENERON PHARMACEUTICALS, INC. (REGN)
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
Valemetostat Tosylate	KYNTRA BIO INC. (KYNB)
vcn-01	Theriva Biologics, Inc. (TOVX)
Veliparib	IGM Biosciences, Inc. (IGMS)
versamune hpv	PDS Biotechnology Corp (PDSB)
vg2025	IO Biotech, Inc. (IOBT)
vidutolimod	REGENERON PHARMACEUTICALS, INC. (REGN)
vidutolimod	CHECKMATE PHARMACEUTICALS, INC. (CMPI)
Vinblastine Sulfate	Assertio Holdings, Inc. (ASRT)
vobramitamab duocarmazine	MACROGENICS INC (MGNX)
Vobramitamab Duocarmazine (vobra duo)	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.0 mg	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.7 mg	MACROGENICS INC (MGNX)
vp-315	Verrica Pharmaceuticals Inc. (VRCA)
vs-7375	Verastem, Inc. (VSTM)
Zentalis	Zentalis Pharmaceuticals, Inc. (ZNTL)
ZIMBERELIMAB	IGM Biosciences, Inc. (IGMS)
zinc gluconate	GH Research PLC (GHRS)

Phase 1(181)

Drug	Company
[177lu]lu-nns309	Novartis AG (NVS)
[225ac]ac-aky-1189	Aktis Oncology Inc. (AKTS)
[64cu]cu-aky-1189	Aktis Oncology Inc. (AKTS)
[68ga]ga-nns309	Novartis AG (NVS)
[ga-68]-pnt6555	ELI LILLY & Co (LLY)
[lu-177]-pnt6555	ELI LILLY & Co (LLY)
111in-etn029	Novartis AG (NVS)
111in-etn029	NOVARTIS AG (NVSEF)
177lu-dfc413	Novartis AG (NVS)
18F-NOTA-ABY-030	FATE THERAPEUTICS INC (FATE)
18F-NOTA-ABY-030	Amneal Pharmaceuticals, Inc. (AMRX)
225ac-etn029	NOVARTIS AG (NVSEF)
225ac-etn029	Novartis AG (NVS)
5-FU	Xencor Inc (XNCR)
68ga-dfc413	Novartis AG (NVS)
68ga-nns309	Novartis AG (NVS)
AB521	EXELIXIS, INC. (EXEL)
Abiraterone acetate	Royalty Pharma plc (RPRX)
Adebrelimab	Merus N.V. (MRUS)
ADI-270	Adicet Bio, Inc. (ACET)
afp-tcr-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
aldesleukin	GH Research PLC (GHRS)
Aminolevulinic Acid	ENANTA PHARMACEUTICALS INC (ENTA)
Androgen Deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Anetumab Ravtansine	ENANTA PHARMACEUTICALS INC (ENTA)
anti-pd-1	TriSalus Life Sciences Inc. (TLSI)
Anti-STEAP1 CAR T-cells	KYNTRA BIO INC. (KYNB)
APR-1051	Aprea Therapeutics, Inc. (APRE)
ARO-HIF2	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
arx305	Ambrx Biopharma Cayman, Inc. (AMAM)
ASP2138	Tango Therapeutics, Inc. (TNGX)
ASP2138	Merus N.V. (MRUS)
ASP2138	Xencor Inc (XNCR)
ASP2138	ENANTA PHARMACEUTICALS INC (ENTA)
ATG-022	Merck & Co., Inc. (MRK)
autologous genetically modified mage a10ᶜ⁷⁹⁶t cells	Adaptimmune Therapeutics PLC (ADAP)
Avelumab	Accustem Sciences Inc. (ACUT)
axn-27m/imm27m	Instil Bio, Inc. (TIL)
ba3182	BioAtla, Inc. (BCAB)
BA3182 (CAB-EpCAM x CAB-CD3)	BioAtla, Inc. (BCAB)
Balstilimab	AGENUS INC (AGEN)
Berzosertib	Merus N.V. (MRUS)
BET Bromodomain Inhibitor ZEN-3694	FATE THERAPEUTICS INC (FATE)
bgb-b2033	BeOne Medicines Ltd. (BEIGF)
bgb-b2033	BeOne Medicines Ltd. (ONC)
BI 764532	Merus N.V. (MRUS)
BI 770371	FATE THERAPEUTICS INC (FATE)
BI 770371	Amneal Pharmaceuticals, Inc. (AMRX)
Birinapant	IGM Biosciences, Inc. (IGMS)
Botensilimab	AGENUS INC (AGEN)
Cabozantinib	Arcus Biosciences, Inc. (RCUS)
Capmatinib	Structure Therapeutics Inc. (GPCR)
CAPOX	Merck & Co., Inc. (MRK)
Casdatifan	Arcus Biosciences, Inc. (RCUS)
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
Cemiplimab	Crinetics Pharmaceuticals, Inc. (CRNX)
cetrelimab	Innovation Pharmaceuticals Inc. (IPIX)
cetrelimab	JOHNSON & JOHNSON (JNJ)
Cetuximab	NEKTAR THERAPEUTICS (NKTR)
cg0070	GH Research PLC (GHRS)
CIML NK cell Infusion	Amneal Pharmaceuticals, Inc. (AMRX)
CIML NK cell Infusion	FATE THERAPEUTICS INC (FATE)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
cosibelimab	Checkpoint Therapeutics, Inc. (CKPT)
Crizotinib	ENANTA PHARMACEUTICALS INC (ENTA)
CTX131	CRISPR Therapeutics AG (CRSP)
dcc-2812	Deciphera Pharmaceuticals, Inc. (DCPH)
dff332	Novartis AG (NVS)
dff332	NOVARTIS AG (NVSEF)
Domvanalimab	Arcus Biosciences, Inc. (RCUS)
EB-SELECT Single-Target CAR-NK Cells	Merus N.V. (MRUS)
Emavusertib	Amneal Pharmaceuticals, Inc. (AMRX)
emi-le	Day One Biopharmaceuticals, Inc. (DAWN)
emi-le	Mersana Therapeutics, Inc. (MRSN)
Encorafenib	FATE THERAPEUTICS INC (FATE)
Enfortumab Vedotin	ImmunityBio, Inc. (IBRX)
Entinostat	Syndax Pharmaceuticals Inc (SNDX)
Enzalutamide	Filana Therapeutics Inc. (FLNA)
Etoposide	Merus N.V. (MRUS)
Fludarabine	KYNTRA BIO INC. (KYNB)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
gen-011	GENOCEA BIOSCIENCES, INC. (GNCA)
gl-onc1	GENELUX Corp (GNLX)
honokiol	GH Research PLC (GHRS)
Iadademstat	ENANTA PHARMACEUTICALS INC (ENTA)
IBRX-042	ImmunityBio, Inc. (IBRX)
IDE034	IDEAYA Biosciences, Inc. (IDYA)
IDE397	IDEAYA Biosciences, Inc. (IDYA)
IDE892	IDEAYA Biosciences, Inc. (IDYA)
ifx-hu2.0	Tyra Biosciences, Inc. (TYRA)
Interleukin-15 Superagonist	FATE THERAPEUTICS INC (FATE)
Interleukin-15 Superagonist	Amneal Pharmaceuticals, Inc. (AMRX)
Ivosidenib	ENANTA PHARMACEUTICALS INC (ENTA)
jnj-86974680	Innovation Pharmaceuticals Inc. (IPIX)
jnj-86974680	JOHNSON & JOHNSON (JNJ)
JNJ-86974680	Janux Therapeutics, Inc. (JANX)
jnj-90301900	Innovation Pharmaceuticals Inc. (IPIX)
jnj-90301900	JOHNSON & JOHNSON (JNJ)
JSB462 Dose 1 QD	Merus N.V. (MRUS)
JSB462 Dose 2 QD	Merus N.V. (MRUS)
ko-2806	Kura Oncology, Inc. (KURA)
leucovorin	PFIZER INC (PFE)
leucovorin	ELI LILLY & Co (LLY)
Leucovorin	Xencor Inc (XNCR)
Leucovorin	Arcus Biosciences, Inc. (RCUS)
ln-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
ly3410738	ELI LILLY & Co (LLY)
ly3962673	ELI LILLY & Co (LLY)
ly4066434	ELI LILLY & Co (LLY)
LY4175408	ELI LILLY & Co (LLY)
mFOLFIRINOX	BioNTech SE (BNTX)
mFOLFIRINOX	Aclaris Therapeutics, Inc. (ACRS)
MK-0482	Merus N.V. (MRUS)
MK-4830	Merus N.V. (MRUS)
Monoclonal antibody BAT6026	Crinetics Pharmaceuticals, Inc. (CRNX)
Muzastotug	IGM Biosciences, Inc. (IGMS)
mvt-1075	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
mvt-2163	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
nana-val	Viracta Therapeutics, Inc. (VIRX)
nelitolimod	TriSalus Life Sciences Inc. (TLSI)
nir178	Novartis AG (NVS)
nir178	NOVARTIS AG (NVSEF)
NKTR-0165	NEKTAR THERAPEUTICS (NKTR)
NKTR-255	NEKTAR THERAPEUTICS (NKTR)
NKTR-288	NEKTAR THERAPEUTICS (NKTR)
NKTR-422	NEKTAR THERAPEUTICS (NKTR)
nogapendekin alfa inbakicept	ImmunityBio, Inc. (IBRX)
NP137	ENANTA PHARMACEUTICALS INC (ENTA)
Olomorasib	ELI LILLY & Co (LLY)
ONT01	ENANTA PHARMACEUTICALS INC (ENTA)
pdr001	Novartis AG (NVS)
pdr001	NOVARTIS AG (NVSEF)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)
Peposertib	Accustem Sciences Inc. (ACUT)
pf-07934040	PFIZER INC (PFE)
pf-08046054	PFIZER INC (PFE)
pf-08052666	PFIZER INC (PFE)
ph-762	Phio Pharmaceuticals Corp. (PHIO)
Photodynamic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
Pidnarulex	Crinetics Pharmaceuticals, Inc. (CRNX)
Pneumococcal 13-valent Conjugate Vaccine	Amneal Pharmaceuticals, Inc. (AMRX)
Polymer-conjugated IL-15 Receptor Agonist NKTR-255	NEKTAR THERAPEUTICS (NKTR)
PTM-101	Merus N.V. (MRUS)
QEQ278	Novartis AG (NVS)
quaratusugene ozeplasmid	Genprex, Inc. (GNPX)
Quemliclustat	Arcus Biosciences, Inc. (RCUS)
rad001	NOVARTIS AG (NVSEF)
rad001	Novartis AG (NVS)
Ramucirumab	Xencor Inc (XNCR)
Ramucirumab	Tango Therapeutics, Inc. (TNGX)
RP2	Replimune Group, Inc. (REPL)
RP3	Replimune Group, Inc. (REPL)
Sapanisertib	Royalty Pharma plc (RPRX)
Sapanisertib	Merus N.V. (MRUS)
sigvotatug vedotin	PFIZER INC (PFE)
sl-279252	Shattuck Labs, Inc. (STTK)
sn301a	Senti Biosciences, Inc. (SNTI)
Sodium Chloride 0.9%	ENANTA PHARMACEUTICALS INC (ENTA)
srf388	Surface Oncology, Inc. (SURF)
STRO-001	SUTRO BIOPHARMA, INC. (STRO)
STRO-003	SUTRO BIOPHARMA, INC. (STRO)
STRO-004	SUTRO BIOPHARMA, INC. (STRO)
stro-006	SUTRO BIOPHARMA, INC. (STRO)
stro-227	SUTRO BIOPHARMA, INC. (STRO)
tagmokitug	Coherus Oncology, Inc. (CHRS)
tbio-4101	GH Research PLC (GHRS)
Testosterone Cypionate	ENANTA PHARMACEUTICALS INC (ENTA)
Testosterone Cypionate	Royalty Pharma plc (RPRX)
Therapeutic Autologous Dendritic Cells	Amneal Pharmaceuticals, Inc. (AMRX)
TYRA-300	Tyra Biosciences, Inc. (TYRA)
TYRA-430	Tyra Biosciences, Inc. (TYRA)
Vibostolimab	Merus N.V. (MRUS)
XmAb819	Xencor Inc (XNCR)
zanzalintinib	EXELIXIS, INC. (EXEL)
Zavedos®	Merus N.V. (MRUS)
zimberelimab	GILEAD SCIENCES, INC. (GILD)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
Zunsemetinib	Tango Therapeutics, Inc. (TNGX)
Zunsemetinib	KYNTRA BIO INC. (KYNB)
Zunsemetinib	Merus N.V. (MRUS)
zw251	Zymeworks Inc. (ZYME)

Preclinical(16)

Drug	Company
amooranin	ENZYMEBIOSYSTEMS (ENZB)
anti-caix	Checkpoint Therapeutics, Inc. (CKPT)
anti-caix antibody	Checkpoint Therapeutics, Inc. (CKPT)
be-smart	ProPhase Labs, Inc. (PRPH)
gtb-5550	GT Biopharma, Inc. (GTBP)
io112	IO Biotech, Inc. (IOBT)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
kur-503	Athenex, Inc. (ATNX)
mipsagargin	REBUS HOLDINGS, INC. (NSPX)
Moderna development candidate - GPC3	Carisma Therapeutics Inc. (CARM)
neo-stc-01	Neon Therapeutics, Inc. (NTGN)
nktr-0166	NEKTAR THERAPEUTICS (NKTR)
oncr-021	Oncorus, Inc. (ONCR)
siRNA targeting Beta2-spectrin	Bullfrog AI Holdings Inc. (BFRG)
sw-3431	SpringWorks Therapeutics, Inc. (SWTX)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Unknown(5)

Drug	Company
bengay heat therapy	JOHNSON & JOHNSON (JNJ)
cabozantinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
neutrogena light therapy aging mask+	JOHNSON & JOHNSON (JNJ)
not specified	ONCOLYTICS BIOTECH INC (ONCY)
stride	ASTRAZENECA PLC (AZN)

N/A(4)

Drug	Company
Crizotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Erlotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 1/Phase 2(27)

Drug	Company
[203pb]pb-psv359	Perspective Therapeutics, Inc. (CATX)
[212pb]pb-mp0712	MOLECULAR PARTNERS AG (MOLN)
[212pb]pb-psv359	Perspective Therapeutics, Inc. (CATX)
avelumab	VACCINEX, INC. (VCNX)
azd9793 intravenous monotherapy	ASTRAZENECA PLC (AZN)
azd9793 subcutaneous monotherapy	ASTRAZENECA PLC (AZN)
cetuximab	Sanofi (SNY)
Cetuximab	ELI LILLY & Co (LLY)
Chemotherapy	Merus N.V. (MRUS)
eli-002 7p	Elicio Therapeutics, Inc. (ELTX)
gen1160	GENMAB A/S (GNMSF)
gen1160	Genmab A/S (GMAB)
gns561 + trametinib	Genfit S.A. (GNFT)
GTAEXS617	RECURSION PHARMACEUTICALS, INC. (RXRX)
hb-201 intravenous administration	HOOKIPA Pharma Inc. (HOOK)
HCW9218	ImmunityBio, Inc. (IBRX)
ino-5401	INOVIO PHARMACEUTICALS, INC. (INO)
ino-9012	INOVIO PHARMACEUTICALS, INC. (INO)
micvotabart pelidotin	Pyxis Oncology, Inc. (PYXS)
osimertinib	Genprex, Inc. (GNPX)
otx-2002	Omega Therapeutics, Inc. (OMGA)
platinum-based chemotherapy	Genprex, Inc. (GNPX)
PSV359	Perspective Therapeutics, Inc. (CATX)
Pumitamig	BioNTech SE (BNTX)
ryz801	RayzeBio, Inc. (RYZB)
sd-101	TriSalus Life Sciences Inc. (TLSI)
will receive hh-009	China Health Industries Holdings, Inc. (CHHE)

Phase 2/Phase 3(14)

Drug	Company
BNT113	BioNTech SE (BNTX)
CAPOX	BRISTOL MYERS SQUIBB CO (BMY)
ficerafusp alfa	Bicara Therapeutics Inc. (BCAX)
fluoropyrimidine-	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
FOLFOX	BRISTOL MYERS SQUIBB CO (BMY)
folinic acid/ leucovorina	AbbVie Inc. (ABBV)
hb-202/hb-201 alternating 2-vector therapy	HOOKIPA Pharma Inc. (HOOK)
ifx-hu2.0	TuHURA Biosciences, Inc./NV (HURA)
inbrx-106	Inhibrx Biosciences, Inc. (INBX)
navlimetostat	BRISTOL MYERS SQUIBB CO (BMY)
nogapendekin alfa	GH Research PLC (GHRS)
pd-1 inhibitor	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
Pemetrexed	AbbVie Inc. (ABBV)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)

Phase 4(41)

Drug	Company
5-Flurouracil	Merus N.V. (MRUS)
5-FU	KYNTRA BIO INC. (KYNB)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
adjuvant chemotherapy	Merus N.V. (MRUS)
Androgen Deprivation Therapy	Royalty Pharma plc (RPRX)
Androgen-deprivation Therapy	Royalty Pharma plc (RPRX)
Apalutamide	KYNTRA BIO INC. (KYNB)
Avelumab	ENANTA PHARMACEUTICALS INC (ENTA)
Baxdrostat and dapagliflozin	Travere Therapeutics, Inc. (TVTX)
bms-986463	BRISTOL MYERS SQUIBB CO (BMY)
bms-986489	BRISTOL MYERS SQUIBB CO (BMY)
bms-986506	BRISTOL MYERS SQUIBB CO (BMY)
Botulinum toxin type A	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin Type A 100U	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin Type A 200U	Revance Therapeutics, Inc. (RVNC)
Brachytherapy	KYNTRA BIO INC. (KYNB)
Cetuximab	IGM Biosciences, Inc. (IGMS)
CPT-11	IGM Biosciences, Inc. (IGMS)
Dapagliflozin along with standard medical therapy	Travere Therapeutics, Inc. (TVTX)
Dapagliflozin Propanediol	Travere Therapeutics, Inc. (TVTX)
Darolutamide	KYNTRA BIO INC. (KYNB)
Darolutamide 300 mg tablets	KYNTRA BIO INC. (KYNB)
Diclofenac Potassium	Assertio Holdings, Inc. (ASRT)
Enfortumab Vedotin	Fulgent Genetics Inc. (FLGT)
Fianlimab	ENANTA PHARMACEUTICALS INC (ENTA)
Investigator's Choice of Therapy	Merus N.V. (MRUS)
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)
Leuprolide	Myovant Sciences Ltd. (MYOV)
Lutetium Lu 177 Vipivotide Tetraxetan	Novartis AG (NVS)
monalizumab	GH Research PLC (GHRS)
Monalizumab	ASTRAZENECA PLC (AZN)
Montelukast	Structure Therapeutics Inc. (GPCR)
Ramucirumab	ENANTA PHARMACEUTICALS INC (ENTA)
Single agent chemotherapy	Merus N.V. (MRUS)
Sodium Thiosulfate	ENANTA PHARMACEUTICALS INC (ENTA)
SOX chemotherapy	Merus N.V. (MRUS)
Talazoparib with enzalutamide	KYNTRA BIO INC. (KYNB)
tislelizumab	GH Research PLC (GHRS)
toripalimab	Coherus Oncology, Inc. (CHRS)
Zibotentan/Dapagliflozin FDC	Travere Therapeutics, Inc. (TVTX)

Compare drugs

afinitor vs axitinib afinitor vs Aybintio (SB8)afinitor vs bicalutamide

Frequently asked questions

How many drugs are in development for Carcinoma?

BioSniper tracks 847 drugs in development for Carcinoma across 184 companies.

How many clinical trials target Carcinoma?

There are 8 clinical trials targeting Carcinoma tracked by BioSniper.

What is the prevalence of Carcinoma?

The estimated prevalence of Carcinoma is approximately 14.0 per 100,000 population.

Deep-dive into Carcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis